Microbiology · Mycobacteria (Tuberculosis, Leprosy, Atypical)

According to the WHO multidrug therapy regimen, paucibacillary leprosy is treated with which combination and total duration?

  • A Rifampicin monthly plus dapsone daily for 12 months
  • B Rifampicin monthly plus clofazimine daily for 24 months
  • C Rifampicin monthly plus dapsone daily for 6 months
  • D Rifampicin and isoniazid daily plus dapsone for 9 months
Correct answer: C. Rifampicin monthly plus dapsone daily for 6 months

Explanation

WHO paucibacillary regimen consists of monthly supervised rifampicin 600 mg plus daily self-administered dapsone 100 mg for a total of 6 months. Multibacillary disease adds daily clofazimine and extends treatment to 12 months under current WHO guidance. Under Indian NLEP convention the same PB regimen of 6 months applies. Clofazimine is not part of the PB regimen, and isoniazid has no role in standard leprosy multidrug therapy.

Reference: Park Textbook of Preventive and Social Medicine, 27th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Mycobacteria (Tuberculosis, Leprosy, Atypical) MCQs

See all Mycobacteria (Tuberculosis, Leprosy, Atypical) MCQs →